State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 351 actively recruiting studies with Michigan sites out of 351 registered in total. The busiest research areas in Michigan are Breast Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (64), Phase 2 (108), Phase 3 (88), Phase 4 (12).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 351 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 351. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06023589 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Plac...
Condition
Asthma
Enrollment
231 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT05526079 Phase 2
Recruiting
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
Condition
Rectal Cancer
Enrollment
30 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06960213 Phase 3
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Condition
Hereditary Angioedema
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
ADARx Pharmaceuticals, Inc.
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
NCT07219420 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants...
Condition
Palmoplantar Pustulosis
Enrollment
320 pts
Location
United States, Canada, China
Sponsor
UCB Biopharma SRL
NCT06402968 N/A
Recruiting
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Condition
Intracerebral Hemorrhage
Enrollment
1,018 pts
Location
United States
Sponsor
Zeenat Qureshi Stroke Institut
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06955013 N/A
Recruiting
Ultrasound to View Abdominal Wall Muscle Layers
Condition
Healthy Volunteers
Enrollment
118 pts
Location
United States
Sponsor
Corewell Health South
NCT06350097 Phase 3
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotama...
Condition
Non-small Cell Lung Cancer
Enrollment
582 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT07197827 Phase 1, Phase 2
Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
424 pts
Location
United States, Australia, China
Sponsor
MediLink Therapeutics (Suzhou)
NCT07335497 Phase 1, Phase 2
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Condition
Locally Advanced / Metastatic Solid Tumors
Enrollment
290 pts
Location
United States, Australia, Ireland
Sponsor
Crescent Biopharma, Inc.
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT05374824 N/A
Recruiting
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure M...
Condition
Lennox Gastaut Syndrome
Enrollment
4,680 pts
Location
United States
Sponsor
Ann & Robert H Lurie Children'
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07540897 Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States
Sponsor
Alkermes, Inc.
NCT06721559 N/A
Recruiting
Empower@Home: Community Implementation for Older Adults With Ambulatory Disabili...
Condition
Depression
Enrollment
64 pts
Location
United States
Sponsor
University of Michigan
NCT05489588 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Condition
Venous Thromboses
Enrollment
165 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT05711394 Phase 3
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atog...
Condition
Episodic Migraine
Enrollment
450 pts
Location
United States, Belgium, Canada
Sponsor
AbbVie
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
NCT06787612 Phase 2
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Plati...
Condition
Ovarian Cancer
Enrollment
220 pts
Location
United States, Canada, South Korea
Sponsor
Regeneron Pharmaceuticals
NCT00345930 N/A
Recruiting
DILIN - Prospective Study
Condition
Liver Diseases
Enrollment
4,000 pts
Location
United States
Sponsor
Duke University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology